[HTML][HTML] Ethical issues in stem cell research and therapy

NMP King, J Perrin - Stem Cell Research & Therapy, 2014 - Springer
Rapid progress in biotechnology has introduced a host of pressing ethical and policy issues
pertaining to stem cell research. In this review, we provide an overview of the most …

[HTML][HTML] The bioethics of stem cell research and therapy

I Hyun - The Journal of clinical investigation, 2010 - Am Soc Clin Investig
Discussion of the bioethics of human stem cell research has transitioned from controversies
over the source of human embryonic stem cells to concerns about the ethical use of stem …

[HTML][HTML] Transposable elements in early human embryo development and embryo models

JA DiRusso, AT Clark - Current opinion in genetics & development, 2023 - Elsevier
Transposable elements (TEs), long discounted as 'selfish genomic elements,'are
increasingly appreciated as the drivers of genomic evolution, genome organization, and …

The US direct-to-consumer marketplace for autologous stem cell interventions

L Turner - Perspectives in biology and medicine, 2018 - muse.jhu.edu
Hundreds of businesses and clinics in the United States are engaged in direct-to-consumer
marketing of unproven and unlicensed stem cell–based interventions. This essay provides …

[HTML][HTML] Mapping the translational science policy 'valley of death'

EM Meslin, A Blasimme… - Clinical and translational …, 2013 - Springer
Translating the knowledge from biomedical science into clinical applications that help
patients has been compared to crossing a valley of death because of the many issues that …

ClinicalTrials. gov, stem cells and 'pay-to-participate'clinical studies

L Turner - Regenerative medicine, 2017 - Taylor & Francis
Numerous US businesses that engage in direct-to-consumer advertising of stem cell
interventions that are not US FDA-approved also recruit clients by listing 'pay-to …

Developing standards to support the clinical translation of stem cells

J Cao, J Hao, L Wang, Y Tan, Y Tian, S Li… - Stem cells …, 2021 - academic.oup.com
Stem cells, which could be developed as starting or raw materials for cell therapy, hold
tremendous promise for regenerative medicine. However, despite multiple fundamental and …

Direct-to-consumer marketing of stem cell interventions by Canadian businesses

L Turner - Regenerative medicine, 2018 - Taylor & Francis
Aim: This study examines marketing claims of Canadian businesses engaged in direct-to-
consumer advertising of putative stem cell treatments. Methods: Internet searches were used …

Experimental heterogeneity and standardisation: stem cell products and the clinical trial process

A Webster, C Haddad, C Waldby - BioSocieties, 2011 - Springer
This article examines developments in the field of regenerative medicine with respect to two
quite distinct models of therapeutic development, a medical innovation model and a 'cells-as …

Selling stem cell 'treatments' as research: prospective customer perspectives from crowdfunding campaigns

J Snyder, L Turner - Regenerative medicine, 2018 - Taylor & Francis
Aim: To better understand how prospective customers interpret claims of businesses
marketing unproven stem cell products that they are engaging in research activities …